|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.88/-1.83
|
企業價值
2.63B
|
資產負債 |
每股賬面淨值
12.61
|
現金流量 |
現金流量率
--
|
損益表 |
收益
8.08M
|
每股收益
0.01
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/09/20 18:38 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer. |